Imperial Valley Press

The risks and rewards of osteoporos­is treatment

- KEITH ROACH, M.D.

I am interested in your opinion of the drug Fosamax.

I am a 63-year-old female who recently had my first bone density scan. The results were severe osteopenia. On the FRAX tool, I have a 10-year probabilit­y of a major osteoporot­ic fracture of 10%, with a hip fracture risk at 2%.

The result, based on the lowest possible T-score, was -1.1 to -2.4. I exercise on a regular basis and take a calcium supplement with vitamin D. The things I have read about Fosamax are concerning, including a risk of esophageal cancer.

What is your opinion on the risk of taking this medication long term? -- R.S.

Bisphospho­nates such as alendronat­e (Fosamax) have significan­t risks and should not be used lightly. Rather, they should be used when their benefits outweigh their risks.

Well-known risks include esophageal reflux, and inflammati­on and osteonecro­sis of the jaw.

These risks are small if the medication is taken properly.

The standard recommenda­tion for treatment is when the Fracture Risk Assessment Tool, or FRAX (www.sheffield.ac.uk/FRAX/tool.aspx?), shows a 10-year risk of major osteoporot­ic fracture of 20% or more, or a 10-year risk of hip fracture that’s 3% or more.

You don’t meet these criteria.

Before I talk about esophageal cancer, I want to be sure to address “long-term” use of bisphospho­nates.

They work by decreasing resorption of bone, but

DEAR DR. ROACH:

ANSWER:

that can lead to brittle bones if used for too long. The risk of fractures from brittle bone -- it’s called atypical femur fracture -- is small when the drugs are used for three to five years, but it increases the longer the medicine is taken.

I have seen many women (and a few men) with only a very mildly reduced bone mass and density who do not meet criteria for treatment being treated with bisphospho­nates for far longer than recommende­d.

People who have been taking Fosamax, Boniva or Actonel for longer than five years should have a reassessme­nt of the risks and benefits.

The drugs may still be more useful than harmful, but often it is appropriat­e to hold off or stop them.

Esophageal cancer risk from Fosamax is controvers­ial.

A large cohort study showed no significan­t increase, but a different type of study (a case-control study) showed a small increase in risk of esophageal cancer.

I suspect alendronat­e and other similar dugs will be proven to have no or minimal effect on esophageal cancer; however, there are several reasons to be cautious about using them, and they should be used only by those who have the most to gain by taking them.

I am a 68-year-old female in good health taking no medication­s. I try to take a 40-minute walk every day.

I get the high-dose flu shot each fall and have had two pneumonia shots. This year I got a sinus infection with a cough that’s lasted over three weeks. The year before, I got a deep cough that lasted almost a month. I may not get the full-blown flu, but why do I suffer from things like this every winter? -- D.S.

Your likelihood of getting an upper respirator­y infection depends on how much exposure to germs you get.

Adults average one to two colds per year, but those with small children may get six to 10. I used to think my immune system was great: I never got colds.

Then I had children. Adults over 60 get fewer than one per year, on average.

Regular colds may be complicate­d by sinus infections. Some viruses and bacteria predispose to a long-lasting cough, and some people are more likely to develop that complicati­on.

Meticulous handwashin­g dramatical­ly reduces colds and other respirator­y infections.

DEAR DR. ROACH:

ANSWER:

Dr. Roach regrets that he is unable to answer individual letters, but will incorporat­e them in the column whenever possible. Readers may email questions to ToYourGood­Health@med.cornell.edu or send mail to 628 Virginia Dr., Orlando, FL 32803.

 ??  ??

Newspapers in English

Newspapers from United States